Capillary Technologies IPO GMP: What It Means & What To Know
The SaaS company Capillary Technologies India Ltd is making its public market debut, and one of the key talking points is its grey market premium (GMP). This number gives a hint of how the listing might go and how investors view the IPO before shares start trading.
While GMP is not official and can change fast, it still offers valuable insight into market sentiment. Understanding this can help decide whether to apply for the IPO now or wait and watch the listing.
Grey Market Premium (GMP) is the unofficial price at which IPO shares are trading in the informal market before they list. If GMP is positive and high, it suggests investors expect the stock to list higher than the issue price. If GMP is zero or negative, it may suggest weak sentiment or limited listing gains.
GMP is not regulated, and should never be the sole basis for a decision. It must be combined with business fundamentals, IPO pricing, subscription trends and long-term outlook. But as one data point it helps gauge the mood of the market.
Capillary Technologies India Ltd is offering shares in a book-built issue which has set the price band at ₹ 549 to ₹ 577 per share. The minimum investment is based on a lot size of 25 shares, which comes to around ₹ 14,425 at the upper band. The issue includes a fresh issue as well as an offer-for-sale (OFS) component.
Its IPO opens on 14 November 2025 and will close on 18 November 2025. The expected listing is around 21 November 2025, subject to allotment and approvals.
In the grey market, the GMP for this IPO has been tracking in the range of ₹ 20–25 per share above the upper band of ₹ 577. That puts an estimated listing price around ₹ 600, reflecting an upside of about 3-5 %.
Earlier, the GMP touched higher levels (around ₹ 50) but has since fallen, showing cooling speculative interest. The moderate GMP suggests the market views the issue as reasonably priced but not highly speculative.
On Day 1 of subscription, the issue was booked around 28 % overall. Retail investors subscribed about 26 %, non-institutional investors around 28 %, and qualified institutional buyers (QIBs) about 29 %. These figures suggest a measured interest rather than an oversubscribed frenzy.
When an IPO has low subscription and a modest GMP, it generally means the expected short-term pop on listing will be limited. That puts more emphasis on picking the IPO for its long-term potential rather than quick listing gains.
When thinking about applying, here are a few points:
Capillary Technologies’ IPO is poised to list with only modest expected upside based on current informal market signals. A GMP of about ₹ 20-25 above the upper issue band suggests a potential listing around ₹ 600 per share. Subscription numbers indicate a cautious market.
If you are a short-term investor you’ll want to weigh whether 3-5 % listing gain is enough. If you believe in the company’s long-term growth in the global software space, then subscribing might make sense at the upper band. Always match your decision with your investment time-horizon, risk appetite and a clear understanding of business fundamentals.
Share This Post